Skip to Content

WW 74 (Letrozole 2.5 mg)

Pill with imprint WW 74 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Arab Pharmaceutical Manufacturing Co. PSC Ltd.

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WW 74

Letrozole

Imprint
WW 74
Strength
2.5 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Arab Pharmaceutical Manufacturing Co. PSC Ltd
National Drug Code (NDC)
24535-0801
Inactive Ingredients
lactose monohydrate, corn starch, sodium starch glycolate type A potato, microcrystalline cellulose, magnesium stearate, polyethylene glycol, titanium dioxide, magnesium silicate, ferric oxide yellow, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "WW 74"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.